Class 2 Medicines Recall: Mercury Pharmaceuticals Ltd, Paliperidone Mercury Pharma Prolonged-release Suspension For Injection In Pre-filled Syringes, El(26)a/01

Recall Summary Mercury Pharmaceuticals Ltd is recalling paliperidone prolonged-release injections in pre-filled syringes in the United Kingdom because manufacturing deficiencies were found at the facility where the finished product is made. This is a Class II recall affecting remaining stock of this medication. The recall is being done as a precaution due to Good Manufacturing Practice standards not being met during an inspection.

Recalling firm

Mercury Pharmaceuticals Ltd

Reason

Mercury Pharmaceuticals Ltd is recalling remaining stock of paliperidone pre-filled syringes as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies cited during a recent inspection at the finished product manufacturing site.

Classification

Class II

Category

drug recall

Country

United Kingdom

Agency

UK Medicines and Healthcare products Regulatory Agency

Recall date

2026-01-20

Status

Ongoing

Distribution

United Kingdom

Official recall notice from UK Medicines and Healthcare products Regulatory Agency

Recall details on Nibble Recalls: https://trynibble.app/recalls/8f277850-826f-4fdd-b282-d6c24fdb325d